NCT04897763 2026-01-07
PERTINENCE
Institut Cancerologie de l'Ouest
Phase EARLY_PHASE1 Completed
Clinical Trials
8 trialsNCT01868087 2024-11-01
Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT03204266 2022-08-24
Oral Supplementation to Enhance Recovery Pilot Study
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT01738815 2021-10-22
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
State University of New York - Upstate Medical University
Phase EARLY_PHASE1 Completed
NCT02753309 2021-03-19
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT02646319 2019-06-06
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT02139371 2014-12-12
Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Rigshospitalet, Denmark
Phase EARLY_PHASE1 Completed
NCT01240824 2014-04-14
BCG
University of Virginia
Phase EARLY_PHASE1 Completed